| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.468 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.468 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
0.468 |
Evidence |
|
| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.468 |
Evidence |
|
| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.468 |
Evidence |
|
| BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
0.468 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.468 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
0.468 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.468 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.468 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.468 |
Evidence |
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.468 |
Evidence |
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.468 |
Evidence |
|
| CRYGS |
CRYGS, GRYG8: Beta-crystallin S |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
0.468 |
Evidence |
|
| FGFR3 |
FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.468 |
Evidence |
|
| FGFR3 |
FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.468 |
Evidence |
|
| FGFR3 |
FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.468 |
Evidence |
|
| FGFR3 |
FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.468 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.468 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.468 |
Evidence |
|
| CAPN3 |
CAPN3, CANP3, CANPL3, NCL1: Calpain-3 |
CST7 |
CST7: Cystatin-F precursor |
0.468 |
Evidence |
|
| CAPN3 |
CAPN3, CANP3, CANPL3, NCL1: Calpain-3 |
CST5 |
CST5: Cystatin-D precursor |
0.468 |
Evidence |
|